PTC Therapeutics, Inc.

Status: Publicly traded

Direct answer

PTC Therapeutics, Inc. is publicly traded on NASDAQ under the ticker PTCT.

PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from early research and preclinical studies to clinical trials—with a...

Can you invest in PTC Therapeutics, Inc.?

Yes. PTC Therapeutics, Inc. is publicly traded on NASDAQ under the ticker PTCT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for PTC Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.